Infectious endocarditis in HIV-infected intensive care unit patients
https://doi.org/10.22625/2072-6732-2022-14-2-73-79
Abstract
Infective endocarditis (IE) is one of the most common cardiac complications in HIV patients who are intravenous drug addicts. The presence of IE and secondary diseases in immunocompromised individuals usually requires specific diagnostic and therapeutic approach.
Aim: Optimizing the diagnosis of IE in patients with advanced HIV/AIDS.
Materials and methods We reviewed 429 case records of HIV/AIDS ICU patients using the modified duke criteria for diagnosis of infective endocarditis. Statistical significance (p <0.05) of data was assessed using the χ2 test.
Results. 25 patients were diagnosed with IE. The male gender dominated – 68%. Mean age was 38. 60% had stage 4B HIV infection. 68% were ART naive. The medium viral load was 294560 copies / ml, while the medium CD4 count was 218 cells / μl. Fever of >38°C was a key symptom found in all patients. Blood cultures were positive in 60% cases. 80% had a high C reactive protein (CRP), and 44% had CRP levels above 100 mg/l. Procalcitonin (PCT) levels were increased in 52%. Echocardiogram revealed IE in 92%. Pneumonia was diagnosed in 92%. Fatal outcome occurred in 76%. Anemia was a predictor of severe outcome (p<0.002), while patients with leukocytosis had good prognosis (p<0.05).
Conclusion. Infective endocarditis is a common complication among HIV IDUs. The most common diagnostic criteria are fever >38°C, pneumonia, anemia, leukocytosis, thrombocytopenia and echocardiographic findings. The levels of the hemoglobin and WBCs could evaluate prognosis of the disease outcome.
About the Authors
T. V. Kharlamova
Peoples Friendship University of Russia
Russian Federation
Russian Federation
Moscow
S. L. Voznesenskiy
Peoples Friendship University of Russia
Russian Federation
Russian Federation
Moscow
T. N. Ermak
Central Research Institute of Epidemiology
Russian Federation
Russian Federation
Moscow
G. M. Kozhevnikova
Peoples Friendship University of Russia
Russian Federation
Russian Federation
Moscow
P. V. Klimkova
Infectious Diseases Clinical Hospital № 2
Russian Federation
Russian Federation
Moscow
References
1. State report on the state of the sanitary and epidemiological expenditure of the population in the Russian Federation in 2020// Federal Service for Supervision of Human Consumption and Consumption: https://www.rospotrebnadzor.ru. – 2021. – URL: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=18266.
2. Ponomareva E.Yu., Rebrov A.P. Infective endocarditis in HIV-infected patients. – Therapy. 2021;7: 152-158 (in Russian)
3. https://dx.doi.org/10.18565/therapy.2021.7.152-158
4. Ruchika Meel. Right-Sided Infective Endocarditis Secondary to Intravenous Drug Abuse//Infective Endocarditis.2019. – DOI: 10.5772/intechopen.84319
5. Ulanova V.I., Mazurov V.I., Zinzerling V.A. Clinical and morphological characteristics of infective endocarditis. Clinical Medicine (Russian Journal). 2020;98(2):115-121. https://doi.org/10.30629/0023-2149-2020-98-2-115-121
6. Infektsionnyye endokardity: rukovodstvo/V.P. Tyurin; pod redaktsiyey YU.L. Shevchenko. – 2-ye izd., dop. i pererab. – M.: GEOTAR-Media, 2013.-368 s.: il. –(Biblioteka vrachaspetsialista)
7. Ponomareva E.Yu., Roshchina A.A., Rebrov A.P. Features of the course of infective endocarditis against the background of HIV / AIDS in injection drug users / / Clinician. -2011;3:19-22 (in Russian)
8. Kadriye Kart Yasar, Filiz Pehlivanoglu, Sevtap Gursoy, Gonul Sengoz. – Tricuspid Endocarditis and Septic Pulmonary Embolism in an Intravenous Drug User with advanced HIV Infection. Oman Medical Journal. – 2011;26(5):365-367
9. Pokrovsky V.V., Yurin O.G., Kravchenko A.V., et al. Recommendations for the treatment of HIV infection and related diseases, chemoprevention of HIV infection. Epidemiology and infectious diseases. Topical issues. 2020;10(S4):1-87 (in Russian)
10. Habib G., Lancellotti P., Antunes M., Bongiorni M., Casalta J., Zotti F., Dulgheru R., Khoury G., Erba P., Iung B., Miro J., Mulder B., Plonska-Gosciniak E., Price S., Roos-Hesselink J., Snygg-Martin U., Thuny F., Mas P., Vilacosta I., Zamorano J., Demin A.A. 2015 ESC Guidelines for the management of infective endocarditis. Russian Journal of Cardiology. 2016;(5):65-116. (In Russ.) https://doi.org/10.15829/1560-4071-2016-5-65-116
11. Khaliullina S.V., Anokhin V.A., Soluyanova Yu.S., Khaliullina K.R., Galina G.V., Khayertynov Kh.S., Aglyamova T.A. Infective endocarditis in HIV-infected intravenous drug users. Practical medicine. 2020. Vol. 18, №1, P. 88-92 DOI: 10.32000/2072-1757-2020-1-88-92
12. Demko I.V., Pelinovskaya L.I., Mankhayeva M.V., Ishchenko O.P., Mosina V.A., Kraposhina A.Yu., Ivanitskaya E.E. Features of infective endocarditis in injection drug users. Russian Journal of Cardiology. 2019;(6):97-102. (In Russ.) https://doi.org/10.15829/1560-4071-2019-6-97-102
13. Chipigina N.S., Karpova N.Yu., Belova M.V., Savilov N.P. Infective endocarditis: diagnostic difficulties. The Clinician. 2020;14(1-2):82-90. (In Russ.) https://doi.org/10.17650/1818-8338-2020-14-1-2-82-90
14. Nunnally, Mark E.; Patel, Arpit Sepsis – What’s new in 2019?, Current Opinion in Anaesthesiology. – 2019;32(2):163-168 DOI: 10.1097/ACO.0000000000000707
15. Beganskaya L A, Roitman A P, Morozov A G, Bugrov A V, Fedorova T A, Dolgov V V. The role of modern markers of systemic inflammation in the diagnosis and prognosis of infective endocarditis course. Laboratory Service. 2017;6(2):7-14. (In Russ.). https://doi.org/10.17116/labs2017627-14
Review
For citations:
Kharlamova T.V., Voznesenskiy S.L., Ermak T.N., Kozhevnikova G.M., Klimkova P.V. Infectious endocarditis in HIV-infected intensive care unit patients. Journal Infectology. 2022;14(2):73-79. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-2-73-79
Views:
1024
.png)
.png)
Email this article 